Abstract
To maintain genome stability, cells have evolved various DNA repair pathways to deal with oxidative DNA damage. DNA damage response (DDR) pathways, including ATM-Chk2 and ATR-Chk1 checkpoints, are also activated in oxidative stress to coordinate DNA repair, cell cycle progression, transcription, apoptosis, and senescence. Several studies demonstrate that DDR pathways can regulate DNA repair pathways. On the other hand, accumulating evidence suggests that DNA repair pathways may modulate DDR pathway activation as well. In this review, we summarize our current understanding of how various DNA repair and DDR pathways are activated in response to oxidative DNA damage primarily from studies in eukaryotes. In particular, we analyze the functional interplay between DNA repair and DDR pathways in oxidative stress. A better understanding of cellular response to oxidative stress may provide novel avenues of treating human diseases, such as cancer and neurodegenerative disorders.
Keywords: AP sites, Base excision repair, Homologous repair, Mismatch repair, Nucleotide excision repair, Oxidative stress-induced DNA damage, Reactive oxygen species
Oxidative stress-induced DNA damage
Oxidative stress
Cells of all organisms are constantly exposed to insults such as oxidative stress from endogenous and exogenous sources. Oxidative stress is defined as an imbalance between the production of reactive oxygen species (ROS) and antioxidant defenses [1–4]. ROS include, but are not limited to, the oxygen molecule (O2), superoxide anion radical (·O2 −), hydrogen peroxide (H2O2), hydroxyl radical (.OH), and singlet oxygen (1O2) [5, 6]. ROS are generated endogenously from normal cellular metabolism such as oxidative phosphorylation in mitochondria and long-chain fatty acids oxidation in peroxisomes [7]. ROS are also formed by exogenous sources such as ionizing radiation (IR), ultraviolet (UV) radiation, chemotherapeutic agents, and environmental agents [7–10]. Representing a major threat to cells, ROS may react with almost all macromolecules including DNA, RNA, proteins, and lipids.
To protect themselves against ROS, cells have evolved several antioxidant defense programs. Antioxidants and protein scavengers can detoxify ROS [11]. Antioxidants include low molecular weight vitamin E (α-tocopherol), vitamin C (ascorbic acid), uric acid, glutathione, β-carotene, and ubiquinone, whereas examples of protein scavengers are hemoglobin and ferritin [11–13]. Furthermore, a variety of antioxidant enzymes, such as superoxide dismutase, catalase, and glutathione-S-transferase, can facilitate reduction reactions of ROS. However, ROS generation periodically exceeds antioxidant defense capacity, leading to oxidative stress in cells. Oxidative stress is implicated in the pathogeneses of cancer, aging, neurodegenerative disorders, diabetes mellitus, obesity, heart failure, cardiovascular diseases, inflammation, ischemia/reperfusion injury, kidney injury/failure, obstructive sleep apnea, and hypertension [14, 15]. Research into oxidative stress is attracting attention of most biomedical disciplines, including both basic and translational research, as evidenced by approximately 121,000 search results in PubMed® using “oxidative stress” as key words.
Oxidative stress-induced DNA damage
“Oxidative DNA damage” is widely used in the literature to describe oxidative stress-induced DNA lesions, whereas “oxidatively damaged DNA” is also recommended [16]. It is estimated that oxidative stress may induce approximately 10,000 DNA alterations per cell per day, representing a major portion of endogenous DNA damage [17–20]. Oxidative stress can induce a variety of different types of DNA damage or replication stress, such as base (purine and pyrimidine) damage, sugar moiety damage, Apurinic/apyrimidinic (AP) sites, DNA single-strand breaks (SSBs), DNA double-strand breaks (DSBs), tandem base modifications (e.g., DNA intrastrand crosslink), DNA interstrand crosslinks, protein–DNA crosslinks, mismatched pairs with damaged bases, stalled DNA replication forks, and oxidatively-generated clustered DNA lesions (OCDLs) [17–21] (Fig. 1). Hydroxyl radicals can react with the purines and pyrimidines of DNA by the addition of double bonds and the abstraction of a H atom (H.) from the methyl group of thymine and from each of the C–H bonds of 2′-deoxyribose. This results in products, such as 5-hydroxymethyl-uracil, C8–OH–adduct radical of guanine, and 8-hydroxyguanine (8-OH-G) [22]. Hydroxyl radicals sometimes target each C atom of the DNA sugar moiety, generating a variety of products, such as 2-deoxypentose-4-ulose, 2-deoxypentonic acid lactone, erythrose, 2-deoxytetradialdose, glycolic acid, and AP sites [9]. Singlet oxygen reacts with all four deoxynucleotide bases with guanine as its preference, generating 8-oxo-7,8-dihydroguanine (8-oxo-G) as the major product [5]. Intrastrand crosslinks, interstrand crosslinks, DSBs, and OCDLs can be formed after exposure to IR and UV radiations [21]. During DNA replication, an oxidatively damaged site may be bypassed by incorporating a mismatched deoxynucleotide (e.g., 8-oxo-G:A) [7]. Chemotherapeutic agents can generate oxidative DNA damage. For example, artesunate can induce 1,N6-ethenoadenine, SSBs and replication-associated DSBs [23–25]. Oxidative stress by hypoxia-reoxygenation in endothelial cells may induce more profound damage, such as chromosomal aberrations (e.g., dicentric chromosomes) and micronuclei [26].
Fig. 1.
Oxidative DNA damage and DNA repair pathways involved in oxidative stress. Base lesion [e.g., 8-oxo-G (8-oxoguanine)], AP site, SSB, and protein–DNA crosslink (e.g., Top1-DNA crosslink) are primarily repaired by BER/SSBR. Mismatched pairs with damaged bases (e.g., 8-oxo-G:T mismatch pairs) are repaired by MMR. NER is involved in removing tandem lesions (e.g., 8,5′-cyclo-2′-deoxyadenosine (cdA) and T-G intrastrand crosslink), whereas DSB is fixed by HR or NHEJ. Dashed circles in red highlight SSB and DSB
To measure oxidative stress-induced DNA damage, a number of analytical and biochemical methods have been developed, including gas chromatography–mass spectrometry (GC–MS), high performance liquid chromatography (HPLC) derived approaches (HPLC–ECD, HPLC–MS/MS, HPLC/MS, and HPLC/32P-postlabeling), immunoassays, and enzymatic assays (comet and alkaline elutions) [27]. Immunofluorescence analysis was used to examine representative oxidative DNA damage 8-oxo-G [28]. Comet assays (single cell gel electrophoresis) were used to measure oxidative stress-induced DNA damage in human lymphocytes from different donors [29]. The Comet-FISH (fluorescence in situ hybridization) technique is used to detect overall and region/site-specific DNA lesions induced by oxidative stress at the individual cell level [30]. However, even with a plethora of techniques, it remains a challenge to measure repair intermediates during the processing of oxidatively damaged DNA.
DNA damage response pathways in oxidative stress
In response to oxidative DNA damage, various DNA repair and DNA damage response (DDR) pathways are employed by cells to maintain genomic integrity [12, 18, 19, 31] (Figs. 1, 2). Base excision repair (BER)/single-strand break repair (SSBR) (Fig. 3), nucleotide excision repair (NER) (Fig. 4), mismatch repair (MMR) (Fig. 5), homologous recombination (HR), and nonhomologous end joining (NHEJ) (Fig. 6) are all involved in the repair processes in response to oxidative DNA damage [7, 18]. Ataxia-telangiectasia mutated (ATM)-Checkpoint kinase 2 (Chk2) and ATM- and Rad3-related (ATR)-Checkpoint kinase 1 (Chk1) checkpoints are the two major DDR pathways induced by oxidatively damaged DNA to coordinate DNA repair process and cell cycle progression (Figs. 2, 7) [31, 32]. Defective DNA repair and DDR pathways may lead to several human diseases, such as cancer and neurodegenerative diseases [6, 33–38] (Fig. 2). To maintain genome stability, the DDR pathways are conserved surveillance mechanisms coordinating DNA repair, cell cycle progression, transcription, apoptosis, and senescence [19, 39–41]. The function of DDR pathways was originally thought to be the alerting of cells to the presence of DNA damage and to arrest cell cycle progress, thus providing extra time for cells to repair DNA damage, such as oxidative DNA damage [31, 42, 43]. The most recent findings are highlighted here regarding how the ATM-Chk2- and ATR-Chk1-dependent DDR pathways are activated in response to oxidative stress.
Fig. 2.
Cellular responses to oxidative DNA damage. DNA repair pathways (BER, NER, MMR, and HR) and DNA damage response pathways (ATM-Chk2 and ATR-Chk1) are integrating into an interacting network in response to oxidative stress. Dashed arrows indicate that potential regulations require more investigations. Defective DNA repair and DDR pathways may lead to diseases such as cancer and neurodegenerative diseases
Fig. 3.
ATM/ATR pathways promote BER/SSBR in response to oxidative DNA damage. AP site is formed after removal of damaged base by DNA glycosylase. SSBs are generated by APE1 at the 5′ side of AP site or bifunctional DNA glycosylase at the 3′ side of AP site, whereas SSBs may also be from other sources. SSBs can be recognized and bound by scaffolding protein XRCC1. A In the short patch sub-pathway, SSB is processed by Pol β to form 1 nt gap. The gap is filled and the final nick is sealed. TDP1 is in charge of removing Topoisomerase I from the protein–DNA crosslink. ATM phosphorylates TDP1 and Chk2. Chk2 then phosphorylates XRCC1. B In the long patch sub-pathway, the 3′ side of SSB is extended by PCNA-tethered DNA polymerases when the 5′ side of SSB can’t be processed into the normal 5′-phosphate. A short strand (~2–13 nt) at the 5′ side of SSB is displaced and further cleaved by PCNA-mediated FEN1. The subsequent nick in the long patch sub-pathway is finally sealed by LIG1. The 9-1-1 complex stimulates enzyme activities of DNA glycosylase, APE1, Pol β, FEN1, and LIG1
Fig. 4.
ATM/ATR pathways interact with NER in response to oxidative DNA damage. In TC-NER, RNA Pol II stops at helix-distorting DNA lesions, which is recognized by CSA/CSB. In GG-NER, the damaged nucleotides are recognized by XPC. The fragment containing the damaged nucleotides is unwound by XPB/XPE together with TFIIH. A pre-incision complex is formed after RPA-mediated XPA recruitment. Dual incisions are achieved at the 5′ side by ERCC1/XPF and at the 3′ side by XPG. Repair synthesis is achieved by the PCNA-mediated DNA Pol δ/ε and followed by ligation via LIG3. XPC, XPA, and XPG regulate ATM directly, whereas XPA also regulates ATR. ATR phosphorylates XPA directly, which is required for the nuclear import and stability and XPA
Fig. 5.
MMR crosstalks with ATM/ATR pathways in response to oxidative DNA damage. Mismatch pairs with damaged base are recognized by MutSα (MSH2 and MSH6) and MutSβ (MSH2 and MSH3), which are required for the binding of MutLα (MLH2 and PMS2) and MutLβ (MLH2 and PMS1), respectively. MutLα/MutLβ may slide away from mismatch pairs and create a nick by the endonuclease activity. The strand containing the mismatch pair may be excised by nucleases such as Exo1 in a PCNA-dependent manner. Pol δ/ε will switch back to fill the gap, and the final nick is sealed by DNA ligase. MSH2, MSH3, and MSH6 may be phosphorylated by ATM/ATR. MSH2 associates with Chk2 while ATM associates with MLH1. ATM phosphorylates MLH1. MSH2 recruits ATR and Chk1 to damaged sites
Fig. 6.
ATM/ATR pathways regulate HR and NHEJ in response to oxidative DNA damage. DSBs can be resected by DNA nuclease, generating RPA-coated ssDNA. Rad51-coated filaments invade the homologous strand and strand synthesis continues to form the D loop. The Double Holliday junctions are resolved to generate crossover or non-crossover products. The Ku complex (KU70/Ku80) is bound to both DSB ends with the absence of homologous chromosome in the NHEJ pathway. The Ku complex is also regulated by ATM/ATR. Subsequently, the DSB ends are processed by the catalytic subunits of DNA-PK (DNA-PKcs) and the broken ends of DSB are finally ligated. The MRN complex at the site of DSB may be phosphorylated by ATM/ATR, whereas ATM may also regulate Rad51
Fig. 7.
ATM/ATR pathways in response to oxidative stress. A Oxidative stress can induce dimerization of ATM via its cysteine residues, leading to structural change in ATM protein and elevated ATM kinase activity. After dissociating from its homodimer, ATM can associate with the MRN complex, which localizes at oxidative stress-derived DSBs, or ATM can associate with MDC1. H2AX is localized to the flanking region of DSB and its phosphorylation mediates the recruitment of MDC1. Activated ATM then phosphorylates its substrates including Chk2. Long stretch of ssDNA is generated through DSB end resection in the 5′–3′ direction via DNA nucleases such as CtIP and Exo1. B Oxidative stress-induced mismatch pairs with base lesion are recognized by MSH2-MSH6 complex. C The helix-distorting DNA lesions are recognized by XPC in GG-NER and further incised by dual enzyme complexes including XPG. A gap of ssDNA can be generated in MMR or NER pathways and extended in the 5′–3′ direction by end resection via DNA nucleases such as Exo1. D Unrepaired SSBs may be processed by PCNA-dependent APE2 in the 3′–5′ direction, generating RPA-coated ssDNA. ATR/ATRIP and the 9-1-1 complex are recruited to RPA-ssDNA independently. TopBP1 bridges the ATR/ATRIP and the 9-1-1 complex and activates ATR kinase directly. Then activated ATR phosphorylates its own downstream substrates, such as Chk1, RPA32, and Rad1
ATM-Chk2 checkpoint activation in oxidative stress
ATM-Chk2 dependent DDR is activated primarily in response to DSBs (Fig. 7) [44]. If not repaired, DSBs can lead to chromosomal aberrations and the dysfunction of key proteins for cell survival or viability [45–47]. Therefore, DSBs are believed to be one of the most detrimental types of DNA damage for cells [46]. ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49]. Under normal conditions, ATM is inactive in a dimer or higher-order oligomer status, when its kinase domain is bound by a region surrounding a critical Serine 1981 and prevented from activation. However, in response to DSBs, ATM auto-phosphorylates Serine 1981, leading to dimer dissociation into a monomer and the full activation of ATM [50, 51]. The MRN complex (Mre11-Rad50-Nbs1) is involved in ataxia-telangiectasia like disease and Nijmegen breakage syndrome and is required for ATM activation in DSB response [52–54]. Acting as a DSB sensor, the MRN complex binds to DSBs and recruits ATM to the broken DNA ends for activation. The unwinding of DSB ends by MRN is also important for ATM stimulation [55, 56]. An in vitro reconstitution analysis further revealed that the MRN complex stimulates ATM kinase activity toward its substrates such as Chk2, p53, and histone H2AX [57] (Fig. 7).
Several mediator proteins are involved in the regulation of ATM activation. As an ATM substrate, histone H2AX is phosphorylated at Serine 139, which is referred to γ-H2AX and prevents DSBs from processing into chromosomal translocations [58, 59]. 53BP1 (p53 binding protein 1) is a tumor suppressor that colocalizes with γ-H2AX and plays an early role in the response to DSBs [60]. With a forkhead-associated (FHA) domain and two BRCT domains, MDC1 is phosphorylated by ATM and relocalizes to damage sites that contain the MRN complex, γ-H2AX, and 53BP1, thereby playing an indispensable role in ATM-dependent DNA damage checkpoint [61]. MDC1 directly binds to γ-H2AX via its BRCT domain to regulate cellular response to DSBs [62, 63]. DDR signaling also utilizes post-translational modifiers, such as ubiquitination and sumoylation, as molecular switches to regulate cellular responses to DSBs [64, 65]. RNF4, a SUMO-targeted ubiquitin E3 ligase, is recruited to DSBs by MDC1 and promotes DNA repair and cellular response to DSBs [66, 67].
ATM appears to be activated in oxidative stress response. In an ischemic retinopathy model, ATM activation by ROS promotes endothelial proliferation by suppressing ROS accumulation as a feedback mechanism [68]. Hydrogen peroxide treatment in primary neuron cells triggers γ-H2AX, indicating DSB generation and ATM activation [69]. Hydrogen peroxide induces p53 phosphorylation at Serine 15 and cell cycle arrest in an ATM-dependent manner in human umbilical vein endothelial cells [70]. Reoxygenation-induced oxidative DNA damage also triggers p53 phosphorylation at Serine 15 [71]. Ochratoxin A, one of the most abundant mycotoxin food contaminants, induces oxidative DNA damage and triggers an ATM-dependent G2 arrest in human gastric epithelium GES-1 cells [72].
As A-T fibroblast cells (ATM−/−) are more susceptible to oxidative stress than normal cells, ATM was proposed as a major sensor of oxidative DNA damage or ROS [73]. Notably, ATM was directly activated by hydrogen peroxide-induced oxidation in the absence of DNA damage, evidenced by ATM auto-phosphorylation at Serine 1981, p53 phosphorylation at Serine 15, and Chk2 phosphorylation at Threonine 68, but not by H2AX phosphorylation at Serine139 [74–76]. Hydrogen peroxide represses mTORC1 in a dose and time-dependent manner, and the mTORC1 repression by ROS requires the presence of ATM in the cytoplasm, suggesting a sub-cellular compartment requirement for ATM signaling in oxidative stress [77]. ATMIN, an ATM interactor protein, was identified as an essential component in the ATM checkpoint pathway in response to oxidative stress. ATMIN mediates oxidative stress-induced ATM activity, thereby protecting the aging brain from accumulating DNA damage [78].
ATR-Chk1 checkpoint activation in oxidative stress
Whereas the ATM-Chk2 checkpoint pathway is activated primarily by DSBs, the ATR-Chk1 checkpoint pathway is activated by replication stress or other types of DNA damage (Fig. 7) [79]. ATR was originally cloned as a member of the phosphoinositide 3-kinase–related kinase (PIKK) family and is essential for early embryonic development [32, 80, 81]. Aberrant expression of ATR results in Seckel syndrome, an autosomal recessive disorder associated with growth retardation and microcephaly [82]. An activated ATR kinase phosphorylates a number of downstream substrates, which are involved in nucleic acid metabolism (DNA replication, DNA repair, DNA recombination, mRNA transcription, and RNA processing), protein metabolism, and cell cycle control [83, 84]. As a critical player in DDR, Chk1 is phosphorylated at Serine 345 by ATR in response to stalled DNA replication forks and DNA damage induced by UV, IR, methyl methanesulfonate (MMS), mitomycin C (MMC), and hydrogen peroxide [85–90]. The phosphorylation of Chk1 enhances Chk1’s kinase activity, which in turn phosphorylates downstream substrates (e.g., Cdc25, BLM, and FANCD2/FANCE) and facilitates cell cycle arrest and DNA damage repair [91–93].
The molecular mechanisms for ATR activation are very complex although a canonical ATR checkpoint signaling pathway has been proposed [94]. 5′-primed ssDNA coated with RPA (RPA-ssDNA) is the determinant DNA structure for ATR activation in response to stalled DNA replication forks or DNA damage [41, 94–96]. A long stretch of ssDNA can be generated through the functional uncoupling of minichromosome maintenance (MCM) helicase and DNA polymerase in DNA replication stress, the DSB end resection by DNA exonuclease such as CtIP in DSB response, the Exo1-mediated processing of NER intermediates after UV radiation, and the SSB end resection by AP endonuclease 2 (APE2) in oxidative stress [86, 97–99] (Fig. 7). ATR-interacting protein ATRIP is recruited to ssDNA via direct interaction between RPA and ATRIP, thereby recruiting ATR to RPA-ssDNA [100, 101]. The PCNA-like clamp 9-1-1 complex (Rad9-Rad1-Hus1) is recruited preferentially to the 5′-primed ssDNA/dsDNA junction by RPA and the clamp loader Rad17-RFC complex [102–105]. The ATR-ATRIP complex and 9-1-1 complexes are recruited to RPA-ssDNA independently and are bridged by the multiple-function protein TopBP1 (Topoisomerase IIβ binding protein 1) [106–110]. TopBP1 contains nine BRCT domains and is required for DNA replication initiation via the recruitment of CDC45 [111, 112]. In response to DNA damage or replication stress, TopBP1 associates with ATR and ATRIP by its C-terminus and Rad9 of the 9-1-1 complex via its N-terminal BRCT domains, which in turn directly activates ATR kinase activity [113–118]. The roles of TopBP1 in DNA replication and DDR can be functionally separated through their distinct BRCT domains [110, 119, 120]. TopBP1 is required for the recruitment of ATR and the 9-1-1 complex onto genotoxin-damaged chromatin or stalled replication forks in Xenopus egg extracts and human cell lines [121–123]. The recruitment of TopBP1 to stalled replication forks or DSBs may also require MDC1/H2AX and the MRN complex [124–126]. Claspin, a Chk1-binding protein, is required for ATR-Chk1 checkpoint activation [127–129]. The circadian protein Tim (Timeless) -Tipin (Timeless-interacting protein) complex associates with ATR-Chk1 checkpoint proteins and plays an essential role in DDR as well [130–133]. After DNA damage is repaired or a pathway selection has been made, the ATR-Chk1 checkpoint will be terminated using checkpoint adaption or a recovery mechanism to resume normal cell cycle progression, which may require Plk1-mediated phosphorylation and subsequent degradation of Claspin [134, 135].
New evidence has been shown that ATR-Chk1 checkpoint signaling is also triggered by oxidative stress. Hyperoxic conditions (95 % oxygen versus the normal 21 % oxygen) resulted in the phosphorylation of Chk1 (Serine 345) and p53 (Serine 15, Serine 37, and Serine 392) in an ATR-dependent but ATM-independent fashion in the lung adenocarcinoma cell line A549 [136]. More recently, it has been demonstrated that hydrogen peroxide triggers ATR-Chk1 checkpoint signaling in human dermal fibroblasts HDF cells [137] and in Xenopus egg extracts [86]. In addition, the natural antioxidant Lycopene inhibits H. pylori-induced gastric diseases associated with oxidative DNA damage (e.g., 8–OH–G and DSBs) and prevents ROS-induced ATM- and ATR-mediated DDR in gastric epithelial AGS cells [138].
Crosstalk between ATM-Chk2 and ATR-Chk1 pathways
It was originally proposed that the ATM-Chk2 and ATR-Chk1 checkpoint pathways work independently in response to different types of replication stress or DNA damage [79]. However, there is a suggestion of crosstalk and transition between these two pathways. In DSB end resection, ATM and the MRN complex are both required for the generation of RPA-ssDNA, the important DNA structure for ATR activation. ATM is essential for the recruitment of ATR to IR-damaged chromatin and Chk1 phosphorylation at Serine 345 [139]. Furthermore, ATM is essential for DSB-induced ATR activation in the S and G2 phases of cell cycle, but not in the G1 phase [140]. Additionally, an ATM-to-ATR switch during the biphasic DSB response was proposed in a report using mammalian cell lysates [141]. Notably, ssDNA may regulate the ATM-to-ATR switch in an ATM and DSB end resection-dependent fashion. Therefore, the DNA end structure determines the molecular mechanism of activating ATM-Chk2 and ATR-Chk1 pathways in an orderly fashion [142].
Alternatively, in response to the DNA methylating agent temozolomide, the ATR-Chk1 checkpoint is activated to arrest cell cycle at G2/M transition. This is followed by ATM-Chk2 checkpoint activation, suggesting ATR functions earlier than ATM [143]. ATM auto-phosphorylation at Ser1981 is ATR-dependent and ATM-independent in response to stalled DNA replication forks or UV-induced DNA damage [144]. In contrast to the IR situation, UV-induced ATM phosphorylation at Serine 1981 does not require the MRN complex, which is a requirement for ATM activation by DSBs. ATR-dependent ATM activation promotes Chk2 phosphorylation downstream of the checkpoint signaling [144]. UV-induced replication stress triggers ATM phosphorylation at Serine 1981, Chk2 phosphorylation at Threonine 68, and H2AX phosphorylation at Serine 139. Further time-dependent experiments revealed that ATM phosphorylation and Chk2 phosphorylation peak after Chk1 phosphorylation. This is consistent with the observation that DSBs are observed in the late phase in response to stalled DNA replication forks [145]. These findings suggest that ATM and ATR may be activated sequentially, the order of which is dependent on the nature of DNA damage or stress (DSBs versus stalled replication forks or UV radiation), and that there is direct cross talk between the two key DDR kinases.
ATM and ATR checkpoint pathways are activated simultaneously by ROS-induced DNA damage in human monocytes [146]. 4-Hydroxynonenal (HNE)-induced DSBs enhance comet tail formation and H2AX phosphorylation in hepatocellular carcinoma cells, suggesting ATM activation [147–149]. HNE also induces caffeine-sensitive ATR phosphorylation at Serine 428 and Chk1 phosphorylation at Serine 296 [147]. Artesunate can cause oxidative DNA damage and trigger the phosphorylation of ATM, Chk2, Chk1, and H2AX, and eventually may lead to apoptosis in human glioblastoma cells [25]. Hydrogen peroxide triggers both ATM phosphorylation at Serine 1981 and Chk1 phosphorylation at Serine 344 in Xenopus egg extracts [86]. However, eliminating ATM kinase activity by its specific inhibitor KU55933 does not affect hydrogen peroxide-induced Chk1 phosphorylation, suggesting ATM may be nonessential for ATR-Chk1 checkpoint activation in oxidative stress response [86]. Together, it remains unclear how ATM and ATR checkpoint pathways regulate each other in response to oxidative stress.
Functional interplay between DNA damage response pathways and DNA repair pathways in oxidative stress
In response to oxidative stress, DDR pathways not only arrest cell cycle progression, but also directly participate in and facilitate DNA repair pathways. Additionally, DNA repair proteins may sense oxidative DNA damage and process such damage into appropriate structures for DDR activation. Thus, DNA repair and DDR pathways are integrated into interacting networks in response to oxidative DNA damage (Fig. 2) [150]. This review focuses on ATM/ATR-mediated DDR pathways and their connections with DNA repair pathways in response to oxidative stress in hopes of providing a comprehensive perspective on this topic.
DNA repair pathways of oxidatively damaged DNA
To repair oxidative DNA damage, several DNA repair pathways, including BER/SSBR, NER, MMR, HR, and NHEJ, are employed by cells to maintain genome stability (Fig. 1) [7, 18]. DNA repair dysfunction was recently proposed to go from a cancer driver to a therapeutic target [151]. These different repair pathways are also integrated with other cellular processes, including cell cycle control, transcription, and replication, suggesting the presence of a DNA repair network used to prevent and repair oxidative DNA damage [152]. Embedded figures provide schematic representations of DNA repair pathways, which highlight the connections with ATM-Chk2 and ATR-Chk1 pathways (Figs. 3, 4, 5, 6). More details of individual DNA repair pathways may be found from other recently published reviews [7, 9, 153–165].
DDR pathways affect DNA repair pathways
It was proposed recently that DDR kinases promote efficient DNA repair by directly regulating the DNA repair machinery, changing the local chromatin environment and cellular environment [166]. Several studies support the role of ATM-Chk2 and ATR-Chk1 pathways for BER, NER, MMR and HR pathways in cellular response to oxidative stress; however, molecular mechanisms of how exactly DDR pathways regulate DNA repair pathways in oxidative stress require more clarity.
ATM-Chk2 checkpoint pathway facilitates DNA repair pathways
Compelling evidence suggests that DDR components participate in and promote the BER pathway, thereby playing a direct role in DNA repair [167]. Chk2-dependent XRCC1 phosphorylation at Threonine 284 promotes the recruitment of XRCC1 to the initial lesion site recognized and excised by the DNA glycosylases MPG and UNG2 (Fig. 3) [168]. Tyrosyl-DNA phosphodiesterase 1 (TDP1) hydrolyzes the phosphodiester bond at a DNA 3′-end linked to a tyrosyl moiety at Topoisomerase I (Top1)-DNA covalent complexes (Fig. 1). TDP1 protects against oxidative DNA damage and has been implicated in SSBR [169]. ATM-dependent TDP1 phosphorylation at Serine 81 facilitates its recruitment to damage sites via XRCC1, thereby promoting cell survival and DNA repair in the human colon carcinoma cell line HCT116 (Fig. 3) [170]. TDP1 also has 3′-phosphoglycolate excision activity, which may contribute to its participation in DSB repair [171].
The ATM-Chk2 pathway is also implicated in the regulation of MMR pathway. The selenium compound and its metabolites (e.g., Na2SeO3, MSeA, or MSeC) induce ROS, such as 8-oxo-G, and cause MLH1-mediated and G2/M arrest in HCT116 [172]. Notably, ATM is required for the selenium-induced MLH1-PMS2 association, which is essential for the repair efficiency [172] (Fig. 5). ATM is essential for MLH1 phosphorylation at Serine 406 and its stability following chemotherapy drug doxorubicin treatment, suggesting the regulation of MMR proteins by ATM [173]. Moreover, ATM plays an important role for the recruitment of Ku complex to hydrogen peroxide-damaged chromatin, further supporting the role of ATM in DSB repair by NHEJ [174, 175] (Fig. 6). In addition, systematic analyses of ATM/ATR substrates have revealed several IR-induced phosphorylation in MMR (e.g., MSH2, MSH3, and MSH6) and HR (e.g., Mre11, Rad50, MDC1, and Rad51) proteins [83] and UV-induced phosphorylation in HR proteins (e.g., Mre11, Rad50, and MDC1) [84] (Figs. 5, 6). It has been demonstrated that Mre11 phosphorylation by ATM/ATR may participate in the checkpoint recovery following DSB repair [176]. Conversely, it remains largely unknown exactly how NER proteins are regulated by ATM pathway (Fig. 2).
ATR-Chk1 checkpoint pathway regulates DNA repair pathways
As a critical component of ATR-Chk1 checkpoint pathway, the 9-1-1 complex interacts with several BER proteins: APE1, Polymerase β (Pol β), FEN1, DNA ligase I, as well as DNA glycosylases MutY, NEIL1, and TDG, thereby stimulating their DNA repair activities [177–185] (Fig. 3). Stimulation by the 9-1-1 complex was unique to Pol β as the 9-1-1 has no effect on replicative DNA polymerases δ and ε. Thus, there is a distinct regulatory role for the 9-1-1 complex in BER pathway. Importantly, the recruitment of the 9-1-1 complex to H2O2-damaged chromatin requires APE2-mediated generation of RPA-ssDNA, suggesting the 9-1-1 complex may promote the BER pathway via a positive feedback mechanism [86]. A PCNA-like toroidal shape and a single repair enzyme-binding site were revealed from the crystal structure of the 9-1-1 complex [186]. However, it remains elusive how the 9-1-1 complex exactly stimulates the BER pathway at almost all steps. More investigations are also needed to test whether the kinase activity of ATR or Chk1 plays a direct role in the regulation of BER pathway.
In response to UV damage, ATR phosphorylates XPA at Serine 196 and regulates the nuclear import of XPA, suggesting that ATR checkpoint modulates the cellular activity of NER pathway [187, 188] (Fig. 4). Further analysis demonstrated that ATR kinase is indeed required for the GG-NER (global genome-NER) of UV-induced damage, such as 6–4 photoproducts (6–4PPs) and cyclobutane pyrimidine dimers (CPDs) [189]. ATR-dependent phosphorylation of XPA at Serine 196 interferes with its binding to HERC2, thereby antagonizing HERC2-mediated ubiquitination and degradation of the XPA protein [190]. Cisplatin-induced nuclear import of XPA is also dependent on an ATR checkpoint in p53-proficient, but not p53-deficient, lung cancer cells [191]. Therefore, ATR kinase has been proposed as a master regulator of NER in S phase [192]. Additionally, activated Chk1 phosphorylates its own substrates such as protein Rad51, which is involved in the DSB repair by HR [193–195] (Fig. 6).
DNA repair proteins are important for DNA damage response in oxidative stress
DNA repair proteins (such as DNA nucleases) may process DNA damage into structures for DDR protein recruitment or recruit DDR proteins to damaged sites via direct protein–protein interactions. This suggests DNA repair proteins may regulate the DDR pathway directly or indirectly [99, 196, 197]. Oxidative stress is emphasized below (Fig. 7).
BER proteins regulate DDR pathways
In the absence of TDP1, unrepaired oxidative DNA damage triggers an ATR/ATM-dependent apoptotic-like response. This infers that ROS under physiological quiescent conditions represent a detrimental threat to genomic stability [198]. Consistent with this observation, MMS induces unresolved BER intermediates in XRCC1-deficient cells and activates ATM and ATR-dependent DDR pathways, including S-phase delay and SMC1 (structural maintenance of chromosomes protein 1) phosphorylation at Serine 966 and Chk1 phosphorylation at Serine 345 [199]. However, it remains elusive whether and how the BER pathway affects DDR directly. A recent study shows that a BER protein APE2 plays several essential roles for ATR-Chk1 checkpoint signaling during oxidative stress [86]. APE2 binds to hydrogen peroxide-damaged chromatin and resects the SSB in the 3′–5′ direction via its 3′-phosphodiesterase and 3′–5′ exonuclease activities, generating RPA-ssDNA. Moreover, APE2 is required for the recruitment of key checkpoint proteins including ATR, ATRIP, and the 9-1-1 complex onto RPA-ssDNA. Additionally, APE2 associates with Chk1 and brings Chk1 to activated ATR for phosphorylation [86] (Fig. 7). Further investigations are needed to test whether other BER proteins play direct roles in the activation of ATR-Chk1 pathway in oxidative stress.
NER proteins regulate DDR pathways
In the NER pathway, XPA, but not CSB, is required for UV-induced Chk1 phosphorylation at Serine 317 and p53 phosphorylation at Serine 15, suggesting that GG-NER but not TC-NER (transcription-coupled NER) is required for ATR-Chk1 checkpoint signaling [200]. UV-induced phosphorylation of H2AX, ATM, and NBS1 was observed in XPB-deficient cells, suggesting TC-NER may be dispensable for ATM checkpoint signaling [201]. DDB2 and XPC recruit ATM and ATR to UV-damaged sites and promote ATM-Chk2 and ATR-Chk1 checkpoint signaling. Moreover, UV-induced H2AX phosphorylation at Serine 139 in G1 cells requires both XPA and XPC [202]. In contrast, ATM and ATR seem to be not essential for the recruitment of DDB2 and XPC to UV-damage sites and the NER repair of CPD and 6–4PP [203]. In addition, XPC and XPG are essential for the recruitment of ATM to damage sites after cisplatin treatment, preventing cisplatin-induced apoptosis [204]. Mechanistic studies revealed that Exo1 localizes with XPA to damage sites after local UV irradiation in non-replicating cells and converts NER intermediates into ssDNA to promote DDR signaling [99, 205]. Notably, it was shown in a biochemically defined system that the gap enlargement by Exo1 is essential for ATR-Chk1 checkpoint activation, indicating that NER and ATR signaling pathways are functionally coupled by Exo1 [206] (Figs. 4, 7).
MMR proteins regulate DDR pathways
Cells with MMR defects are more resistant to death by DNA damaging reagents (e.g., alkylating or methylating agents), suggesting the MMR system may play an upstream role for the DDR signaling pathways [207]. Both in vitro and in vivo evidence have shown that MSH2 binds to Chk2 and that MLH1 associates with ATM. The interactions between MMR and DDR proteins (i.e., MSH2-Chk2 and MLH1-ATM) promote the recruitment of DDR proteins to IR-damaged sites and facilitate Chk2 phosphorylation by ATM [196] (Fig. 5). Furthermore, MSH2 is also required for the appropriate relocalization of the MRN complex (Mre11 and Rad50) to IR-induced damage sites [208]. These observations suggest that the MMR pathway plays an essential regulatory role in the ATM checkpoint pathway including ATM, Chk2, and the MRN complex.
SN1-type DNA alkylating agents induce DNA adducts, such as O6-meG (O6-methylguanine), and activate the ATR-Chk1 pathway. MutSα specifically recognizes O6-meG:T mismatch, but not O6-meG:C, suggesting that MMR proteins can act as direct sensors of mismatches with methylation damage. MutSα also recruits ATR-ATRIP to O6-meG:T, indicating MutSα plays an upstream role for ATR checkpoint signaling [197]. This observation is consistent with the scenario of the anticancer drug 5-fluoro-2′-deoxyuridine (FdU), which may cause mismatch pairs of FdU:G via direct incorporation during DNA replication. ATR-Chk1-dependent DDR is activated by FdU treatment during S phase in a MutSα- and MutLα-dependent manner [209]. Furthermore, MutSα recognizes and associates with FdU:G mismatch pairs in an in vitro binding experiment, whereas FdU may be excised by the uracil glycosylase Smug1 to protect cells from death [210, 211]. These findings suggest that MMR proteins may function as sensors of mismatched DNA lesions and bring DDR proteins to damage sites to activate an appropriate ATR-Chk1 checkpoint.
In response to DNA damage induced by the DNA methylating agent N-methyl-N′-nitro-N-nitrosoguanidine (MNNG), MSH2 associates with ATR/ATRIP and regulates MNNG-induced phosphorylation of Chk1 at Serine 317 and SMC1 at Serine 966 [212]. Furthermore, MLH1 is also required for MNNG-induced ATR checkpoint activation such as Chk1 phosphorylation and the colocalization of γ-H2AX and RPA [213]. Furthermore, the MNNG-induced recruitment of ATR, TopBP1, and Chk1 to chromatin requires MutSα and MutLα, suggesting the MMR pathway is required for ATR-Chk1 checkpoint activation [214]. Systematic analysis of the interactions between MMR and ATR-Chk1 pathways via nuclear co-immunoprecipitation assays have shown that MutSα associates with ATR, TopBP1, Claspin, and Chk1 (but not Rad17, Rad9, or RPA), whereas MutLα interacts only with TopBP1 and Claspin [214]. Additionally, the chemotherapeutic drug cisplatin induces MSH2-mediated and ATR-dependent p53 phosphorylation at Serine 15 and Chk2 phosphorylation at Threonine 68 in rat kidney proximal tubular cells. This suggests the involvement of a MMR protein in ATR activation in response to cisplatin-induced oxidative stress [215, 216]. Moreover, MSH2 recruits ATR to damage sites induced by another DNA methylating agent N-methyl-N-nitrosourea, which is independent of the 9-1-1 complex, Rad17, and RPA [217]. Together, these findings advocate that MMR proteins regulate the ATR-mediated DDR pathway in response to a wide spectrum of DNA damage, including oxidative DNA damage.
HR proteins regulate DDR pathways
The MRN complex is required for the activation of ATM and ATR-dependent DDR pathways in response to DSBs and stalled DNA replication forks, respectively [57, 125, 218]. The MRN complex, MDC1, and H2AX are essential for the recruitment of ATM to the site of DSBs for efficient ATM-mediated DDR activation. However, the prolonged binding to chromatin by repair proteins, such as Mre11, Nbs1 and MDC1, can elicit an ATM-dependent DDR in the absence of DNA damage, suggesting that DDR activation requires the stable association of DNA repair proteins in HR, but not DNA damage per se [219]. Furthermore, DSB end processing in HR also contributes to DDR pathways. CtIP is required for DSB end resection, the recruitment of RPA and ATR to DSBs, and subsequent ATR activation [98, 220]. DNA nucleases (such as DNA2 and Exo1) also contribute to the DSB end resection and subsequent ATM-ATR transition [221] (Fig. 7). Thus, in response to DSBs, ATM may be recruited to the DSB end by the MRN complex and other proteins for activation, whereas ATR is activated after DSB end resection by enzymes such as CtIP and Exo1 (Fig. 7).
Concluding remarks
To maintain genome stability, DNA repair and DDR pathways have evolved as the two major cellular responses to oxidative stress-induced DNA damage [7, 31] (Figs. 1, 7). Dysfunctions in these pathways are linked to cancer and neurodegenerative diseases [6, 33–38] (Fig. 2). Moreover, factors involved in DNA repair and DDR pathways have become therapeutic targets and are currently being tested in both laboratory and clinical studies [151, 222]. We hope we have provided a comprehensive review of the functional interplay between ATM/ATR-mediated DDR pathways and various DNA repair pathways (BER, NER, MMR, and HR) in response to oxidative stress with a focus on higher eukaryotic model organisms.
However, there are still unresolved questions regarding the cellular responses to oxidative DNA damage. Many of the critical barriers in the field include: (1) it is challenging to quantitatively measure oxidatively-generated DNA damage while not measuring intermediate repair products; (2) it remains elusive how accumulation of unrepaired oxidative DNA damage leads to cancer and neurodegenerative diseases; (3) more intense investigations are needed to better understand the potential interplay between ATM/ATR-mediated DDR pathways and DNA damage tolerance pathways in oxidative stress responses; and (4) it is unclear how the ATM-Chk2 and ATR-Chk1 pathways crosstalk with each other in response to oxidative stress. Overall, more intense molecular mechanistic studies of how oxidative DNA damage is repaired and signaled via various integrated DNA repair and DDR pathways will provide new avenues for the treatment of diseases such as cancer and neurodegenerative disorders.
Acknowledgments
The research in the Yan lab is supported in part by funds provided by University of North Carolina at Charlotte and a Grant from the NIGMS/NIH (R15 GM101571). We apologize to our colleagues whose publications were not cited due to space limitations.
Abbreviations
- 9-1-1 complex
Rad9-Rad1-Hus1
- AP
Apurinic/apyrimidinic
- APE1
AP endonuclease 1
- APE2
AP endonuclease 2
- A-T
Ataxia-telangiectasia
- ATM
A-T mutated
- ATR
ATM- and Rad3-related
- BER
Base excision repair
- Chk1
Checkpoint kinase 1
- Chk2
Checkpoint kinase 2
- DDR
DNA damage response
- DSB
Double-strand break
- GG-NER
Global genome NER
- HR
Homologous recombination
- Ku complex
Ku70/Ku80
- MCM
Minichromosome maintenance
- MMR
Mismatch repair
- MRN complex
Mre11-Rad50-Nbs1
- NER
Nucleotide excision repair
- NHEJ
Non-homologous end joining
- PCNA
Proliferating cell nuclear antigen
- ROS
Reactive oxygen species
- RPA
Replication protein A
- SSB
Single-strand break
- SSBR
SSB repair
- ssDNA
Single-stranded DNA
- TC-NER
Transcription-coupled NER
- TDP1
Tyrosyl-DNA phosphodiesterase 1
- γ-H2AX
H2AX phosphorylation at Serine 139
References
- 1.Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997;82(2):291–295. doi: 10.1113/expphysiol.1997.sp004024. [DOI] [PubMed] [Google Scholar]
- 2.Betteridge DJ. What is oxidative stress? Metabolism. 2000;49(2 Suppl 1):3–8. doi: 10.1016/s0026-0495(00)80077-3. [DOI] [PubMed] [Google Scholar]
- 3.Jones DP. Redefining oxidative stress. Antioxid Redox Signal. 2006;8(9–10):1865–1879. doi: 10.1089/ars.2006.8.1865. [DOI] [PubMed] [Google Scholar]
- 4.de M Bandeira S, da Fonseca LJ, da SGG, Rabelo LA, Goulart MO, Vasconcelos SM. Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci. 2013;14(2):3265–3284. doi: 10.3390/ijms14023265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Agnez-Lima LF, Melo JT, Silva AE, Oliveira AH, Timoteo AR, Lima-Bessa KM, Martinez GR, Medeiros MH, Di Mascio P, Galhardo RS, Menck CF. DNA damage by singlet oxygen and cellular protective mechanisms. Mutat Res. 2012;751(1):15–28. doi: 10.1016/j.mrrev.2011.12.005. [DOI] [PubMed] [Google Scholar]
- 6.Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA. 1993;90(17):7915–7922. doi: 10.1073/pnas.90.17.7915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Berquist BR, Wilson DM., 3rd Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. Cancer Lett. 2012;327(1–2):61–72. doi: 10.1016/j.canlet.2012.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 1994;65(1):27–33. doi: 10.1080/09553009414550041. [DOI] [PubMed] [Google Scholar]
- 9.Dizdaroglu M. Oxidatively induced DNA damage: mechanisms, repair and disease. Cancer Lett. 2012;327(1–2):26–47. doi: 10.1016/j.canlet.2012.01.016. [DOI] [PubMed] [Google Scholar]
- 10.Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB. Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol. 2004;14(3):259–266. doi: 10.1016/j.semradonc.2004.04.001. [DOI] [PubMed] [Google Scholar]
- 11.Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) 2002;1(1):3–25. doi: 10.1016/s1568-7864(01)00007-6. [DOI] [PubMed] [Google Scholar]
- 12.Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair (Amst) 2004;3(8–9):1109–1115. doi: 10.1016/j.dnarep.2004.03.002. [DOI] [PubMed] [Google Scholar]
- 13.Gafter-Gvili A, Zingerman B, Rozen-Zvi B, Ori Y, Green H, Lubin I, Malachi T, Gafter U, Herman-Edelstein M. Oxidative stress-induced DNA damage and repair in human peripheral blood mononuclear cells: protective role of hemoglobin. PLoS One. 2013;8(7):e68341. doi: 10.1371/journal.pone.0068341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Gutowski M, Kowalczyk S. A study of free radical chemistry: their role and pathophysiological significance. Acta Biochim Pol. 2013;60(1):1–16. [PubMed] [Google Scholar]
- 15.Rubattu S, Mennuni S, Testa M, Mennuni M, Pierelli G, Pagliaro B, Gabriele E, Coluccia R, Autore C, Volpe M. Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress? Int J Mol Sci. 2013;14(11):23011–23032. doi: 10.3390/ijms141123011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Cadet J, Loft S, Olinski R, Evans MD, Bialkowski K, Richard Wagner J, Dedon PC, Moller P, Greenberg MM, Cooke MS. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic Res. 2012;46(4):367–381. doi: 10.3109/10715762.2012.659248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lindahl T. Instability and decay of the primary structure of DNA. Nature. 1993;362:709–715. doi: 10.1038/362709a0. [DOI] [PubMed] [Google Scholar]
- 18.Friedberg EC. DNA damage and repair. Nature. 2003;421(6921):436–440. doi: 10.1038/nature01408. [DOI] [PubMed] [Google Scholar]
- 19.Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40(2):179–204. doi: 10.1016/j.molcel.2010.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361(15):1475–1485. doi: 10.1056/NEJMra0804615. [DOI] [PubMed] [Google Scholar]
- 21.Cadet J, Ravanat JL, TavernaPorro M, Menoni H, Angelov D. Oxidatively generated complex DNA damage: tandem and clustered lesions. Cancer Lett. 2012;327(1–2):5–15. doi: 10.1016/j.canlet.2012.04.005. [DOI] [PubMed] [Google Scholar]
- 22.Neeley WL, Essigmann JM. Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products. Chem Res Toxicol. 2006;19(4):491–505. doi: 10.1021/tx0600043. [DOI] [PubMed] [Google Scholar]
- 23.Litwin I, Bocer T, Dziadkowiec D, Wysocki R. Oxidative stress and replication-independent DNA breakage induced by arsenic in Saccharomyces cerevisiae. PLoS Genet. 2013;9(7):e1003640. doi: 10.1371/journal.pgen.1003640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kessel M, Liu SX, Xu A, Santella R, Hei TK. Arsenic induces oxidative DNA damage in mammalian cells. Mol Cell Biochem. 2002;234–235(1–2):301–308. [PubMed] [Google Scholar]
- 25.Berdelle N, Nikolova T, Quiros S, Efferth T, Kaina B. Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Mol Cancer Ther. 2011;10(12):2224–2233. doi: 10.1158/1535-7163.MCT-11-0534. [DOI] [PubMed] [Google Scholar]
- 26.Bresgen N, Karlhuber G, Krizbai I, Bauer H, Bauer HC, Eckl PM. Oxidative stress in cultured cerebral endothelial cells induces chromosomal aberrations, micronuclei, and apoptosis. J Neurosci Res. 2003;72(3):327–333. doi: 10.1002/jnr.10582. [DOI] [PubMed] [Google Scholar]
- 27.Cadet J, Douki T, Ravanat JL. Measurement of oxidatively generated base damage in cellular DNA. Mutat Res. 2011;711(1–2):3–12. doi: 10.1016/j.mrfmmm.2011.02.004. [DOI] [PubMed] [Google Scholar]
- 28.Lee SF, Pervaiz S. Assessment of oxidative stress-induced DNA damage by immunoflourescent analysis of 8-oxodG. Methods Cell Biol. 2011;103:99–113. doi: 10.1016/B978-0-12-385493-3.00005-X. [DOI] [PubMed] [Google Scholar]
- 29.Andersson M, Stenqvist P, Hellman B. Interindividual differences in initial DNA repair capacity when evaluating H2O2-induced DNA damage in extended-term cultures of human lymphocytes using the comet assay. Cell Biol Toxicol. 2007;23(6):401–411. doi: 10.1007/s10565-007-9002-5. [DOI] [PubMed] [Google Scholar]
- 30.Glei M, Hovhannisyan G, Pool-Zobel BL. Use of Comet-FISH in the study of DNA damage and repair: review. Mutat Res. 2009;681(1):33–43. doi: 10.1016/j.mrrev.2008.01.006. [DOI] [PubMed] [Google Scholar]
- 31.Chen BP, Li M, Asaithamby A. New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress. Cancer Lett. 2012;327(1–2):103–110. doi: 10.1016/j.canlet.2011.12.004. [DOI] [PubMed] [Google Scholar]
- 32.Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol. 2008;9(8):616–627. doi: 10.1038/nrm2450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wallace SS, Murphy DL, Sweasy JB. Base excision repair and cancer. Cancer Lett. 2012;327(1–2):73–89. doi: 10.1016/j.canlet.2011.12.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Raetz AG, Xie Y, Kundu S, Brinkmeyer MK, Chang C, David SS. Cancer-associated variants and a common polymorphism of MUTYH exhibit reduced repair of oxidative DNA damage using a GFP-based assay in mammalian cells. Carcinogenesis. 2012;33(11):2301–2309. doi: 10.1093/carcin/bgs270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Xiao X, Melton DW, Gourley C. Mismatch repair deficiency in ovarian cancer—molecular characteristics and clinical implications. Gynecol Oncol. 2013;132(2):506–512. doi: 10.1016/j.ygyno.2013.12.003. [DOI] [PubMed] [Google Scholar]
- 36.Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer. 2008;8(3):193–204. doi: 10.1038/nrc2342. [DOI] [PubMed] [Google Scholar]
- 37.Bouwman P, Jonkers J. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat Rev Cancer. 2012;12(9):587–598. doi: 10.1038/nrc3342. [DOI] [PubMed] [Google Scholar]
- 38.Hegde ML, Mantha AK, Hazra TK, Bhakat KK, Mitra S, Szczesny B. Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases. Mech Ageing Dev. 2012;133(4):157–168. doi: 10.1016/j.mad.2012.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071–1078. doi: 10.1038/nature08467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Marechal A, Zou L (2013) DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol 5(9):a012716. doi:10.1101/cshperspect.a012716 [DOI] [PMC free article] [PubMed]
- 41.Branzei D, Foiani M. Maintaining genome stability at the replication fork. Nat Rev Mol Cell Biol. 2010;11(3):208–219. doi: 10.1038/nrm2852. [DOI] [PubMed] [Google Scholar]
- 42.Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001;15(17):2177–2196. doi: 10.1101/gad.914401. [DOI] [PubMed] [Google Scholar]
- 43.Harrison JC, Haber JE. Surviving the breakup: the DNA damage checkpoint. Annu Rev Genet. 2006;40:209–235. doi: 10.1146/annurev.genet.40.051206.105231. [DOI] [PubMed] [Google Scholar]
- 44.Finn K, Lowndes NF, Grenon M. Eukaryotic DNA damage checkpoint activation in response to double-strand breaks. Cell Mol Life Sci. 2012;69(9):1447–1473. doi: 10.1007/s00018-011-0875-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Karagiannis TC, El-Osta A. Double-strand breaks: signaling pathways and repair mechanisms. Cell Mol Life Sci. 2004;61(17):2137–2147. doi: 10.1007/s00018-004-4174-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001;27(3):247–254. doi: 10.1038/85798. [DOI] [PubMed] [Google Scholar]
- 47.van Gent DC, Hoeijmakers JH, Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet. 2001;2(3):196–206. doi: 10.1038/35056049. [DOI] [PubMed] [Google Scholar]
- 48.Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol. 2008;9(10):759–769. doi: 10.1038/nrm2514. [DOI] [PubMed] [Google Scholar]
- 49.Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268(5218):1749–1753. doi: 10.1126/science.7792600. [DOI] [PubMed] [Google Scholar]
- 50.Bakkenist CJ, Kastan MB. Initiating cellular stress responses. Cell. 2004;118(1):9–17. doi: 10.1016/j.cell.2004.06.023. [DOI] [PubMed] [Google Scholar]
- 51.Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421(6922):499–506. doi: 10.1038/nature01368. [DOI] [PubMed] [Google Scholar]
- 52.Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 2003;22(20):5612–5621. doi: 10.1093/emboj/cdg541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.van den Bosch M, Bree RT, Lowndes NF. The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep. 2003;4(9):844–849. doi: 10.1038/sj.embor.embor925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Costanzo V, Paull T, Gottesman M, Gautier J. Mre11 assembles linear DNA fragments into DNA damage signaling complexes. PLoS Biol. 2004;2(5):E110. doi: 10.1371/journal.pbio.0020110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Lee JH, Paull TT. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science. 2005;308(5721):551–554. doi: 10.1126/science.1108297. [DOI] [PubMed] [Google Scholar]
- 56.Lee JH, Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene. 2007;26(56):7741–7748. doi: 10.1038/sj.onc.1210872. [DOI] [PubMed] [Google Scholar]
- 57.Lee JH, Paull TT. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science. 2004;304(5667):93–96. doi: 10.1126/science.1091496. [DOI] [PubMed] [Google Scholar]
- 58.Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273(10):5858–5868. doi: 10.1074/jbc.273.10.5858. [DOI] [PubMed] [Google Scholar]
- 59.Franco S, Gostissa M, Zha S, Lombard DB, Murphy MM, Zarrin AA, Yan C, Tepsuporn S, Morales JC, Adams MM, Lou Z, Bassing CH, Manis JP, Chen J, Carpenter PB, Alt FW. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol Cell. 2006;21(2):201–214. doi: 10.1016/j.molcel.2006.01.005. [DOI] [PubMed] [Google Scholar]
- 60.Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol. 2000;151(7):1381–1390. doi: 10.1083/jcb.151.7.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Goldberg M, Stucki M, Falck J, D’Amours D, Rahman D, Pappin D, Bartek J, Jackson SP. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature. 2003;421(6926):952–956. doi: 10.1038/nature01445. [DOI] [PubMed] [Google Scholar]
- 62.Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell. 2005;123(7):1213–1226. doi: 10.1016/j.cell.2005.09.038. [DOI] [PubMed] [Google Scholar]
- 63.Lou Z, Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, Celeste A, Manis JP, van Deursen J, Nussenzweig A, Paull TT, Alt FW, Chen J. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell. 2006;21(2):187–200. doi: 10.1016/j.molcel.2005.11.025. [DOI] [PubMed] [Google Scholar]
- 64.Huen MS, Grant R, Manke I, Minn K, Yu X, Yaffe MB, Chen J. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell. 2007;131(5):901–914. doi: 10.1016/j.cell.2007.09.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, Jackson SP. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature. 2009;462(7275):935–939. doi: 10.1038/nature08657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Yin Y, Seifert A, Chua JS, Maure JF, Golebiowski F, Hay RT. SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev. 2012;26(11):1196–1208. doi: 10.1101/gad.189274.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Galanty Y, Belotserkovskaya R, Coates J, Jackson SP. RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. Genes Dev. 2012;26(11):1179–1195. doi: 10.1101/gad.188284.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Okuno Y, Nakamura-Ishizu A, Otsu K, Suda T, Kubota Y. Pathological neoangiogenesis depends on oxidative stress regulation by ATM. Nat Med. 2012;18(8):1208–1216. doi: 10.1038/nm.2846. [DOI] [PubMed] [Google Scholar]
- 69.Singh S, Englander EW. Nuclear depletion of apurinic/apyrimidinic endonuclease 1 (Ape1/Ref-1) is an indicator of energy disruption in neurons. Free Radic Biol Med. 2012;53(9):1782–1790. doi: 10.1016/j.freeradbiomed.2012.07.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Chen K, Albano A, Ho A, Keaney JF., Jr Activation of p53 by oxidative stress involves platelet-derived growth factor-beta receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation. J Biol Chem. 2003;278(41):39527–39533. doi: 10.1074/jbc.M304423200. [DOI] [PubMed] [Google Scholar]
- 71.Hammond EM, Dorie MJ, Giaccia AJ. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem. 2003;278(14):12207–12213. doi: 10.1074/jbc.M212360200. [DOI] [PubMed] [Google Scholar]
- 72.Cui J, Liu J, Wu S, Wang Y, Shen H, Xing L, Wang J, Yan X, Zhang X. Oxidative DNA damage is involved in ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro. Arch Toxicol. 2013;87(10):1829–1840. doi: 10.1007/s00204-013-1043-3. [DOI] [PubMed] [Google Scholar]
- 73.Rotman G, Shiloh Y. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? BioEssays. 1997;19(10):911–917. doi: 10.1002/bies.950191011. [DOI] [PubMed] [Google Scholar]
- 74.Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science. 2010;330(6003):517–521. doi: 10.1126/science.1192912. [DOI] [PubMed] [Google Scholar]
- 75.Ambrose M, Gatti RA. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood. 2013;121(20):4036–4045. doi: 10.1182/blood-2012-09-456897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Bhatti S, Kozlov S, Farooqi AA, Naqi A, Lavin M, Khanna KK. ATM protein kinase: the linchpin of cellular defenses to stress. Cell Mol Life Sci. 2011;68(18):2977–3006. doi: 10.1007/s00018-011-0683-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, Inoki K, Guan KL, Shen J, Person MD, Kusewitt D, Mills GB, Kastan MB, Walker CL. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci USA. 2010;107(9):4153–4158. doi: 10.1073/pnas.0913860107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Kanu N, Penicud K, Hristova M, Wong B, Irvine E, Plattner F, Raivich G, Behrens A. The ATM cofactor ATMIN protects against oxidative stress and accumulation of DNA damage in the aging brain. J Biol Chem. 2010;285(49):38534–38542. doi: 10.1074/jbc.M110.145896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell. 2007;28(5):739–745. doi: 10.1016/j.molcel.2007.11.015. [DOI] [PubMed] [Google Scholar]
- 80.Cimprich KA, Shin TB, Keith CT, Schreiber SL. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc Natl Acad Sci USA. 1996;93(7):2850–2855. doi: 10.1073/pnas.93.7.2850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Brown EJ, Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 2000;14(4):397–402. [PMC free article] [PubMed] [Google Scholar]
- 82.O’Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet. 2003;33(4):497–501. doi: 10.1038/ng1129. [DOI] [PubMed] [Google Scholar]
- 83.Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007;316(5828):1160–1166. doi: 10.1126/science.1140321. [DOI] [PubMed] [Google Scholar]
- 84.Stokes MP, Rush J, Macneill J, Ren JM, Sprott K, Nardone J, Yang V, Beausoleil SA, Gygi SP, Livingstone M, Zhang H, Polakiewicz RD, Comb MJ. Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci USA. 2007;104(50):19855–19860. doi: 10.1073/pnas.0707579104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Guo Z, Kumagai A, Wang SX, Dunphy WG. Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev. 2000;14(21):2745–2756. doi: 10.1101/gad.842500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Willis J, Patel Y, Lentz BL, Yan S. APE2 is required for ATR-Chk1 checkpoint activation in response to oxidative stress. Proc Natl Acad Sci USA. 2013;110(26):10592–10597. doi: 10.1073/pnas.1301445110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol. 2001;21(13):4129–4139. doi: 10.1128/MCB.21.13.4129-4139.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Yan S, Willis J. WD40-repeat protein WDR18 collaborates with TopBP1 to facilitate DNA damage checkpoint signaling. Biochem Biophys Res Commun. 2013;431(3):466–471. doi: 10.1016/j.bbrc.2012.12.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Willis J, Destephanis D, Patel Y, Gowda V, Yan S. Study of the DNA damage checkpoint using Xenopus egg extracts. J Vis Exp. 2012;69:e4449. doi: 10.3791/4449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Bai L, Michael WM, Yan S. Importin beta-dependent nuclear import of TopBP1 in ATR-Chk1 checkpoint in Xenopus egg extracts. Cell Signal. 2014;26(5):857–867. doi: 10.1016/j.cellsig.2014.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Sanchez Y. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science. 1997;277(5331):1497–1501. doi: 10.1126/science.277.5331.1497. [DOI] [PubMed] [Google Scholar]
- 92.Boddy MN. Replication checkpoint enforced by kinases Cds1 and Chk1. Science. 1998;280(5365):909–912. doi: 10.1126/science.280.5365.909. [DOI] [PubMed] [Google Scholar]
- 93.Zhang Y, Hunter T. Roles of Chk1 in cell biology and cancer therapy. Int J Cancer. 2013;134(5):1013–1023. doi: 10.1002/ijc.28226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Nam EA, Cortez D. ATR signalling: more than meeting at the fork. Biochem J. 2011;436(3):527–536. doi: 10.1042/BJ20102162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nat Rev Mol Cell Biol. 2004;5(10):792–804. doi: 10.1038/nrm1493. [DOI] [PubMed] [Google Scholar]
- 96.MacDougall CA, Byun TS, Van C, Yee MC, Cimprich KA. The structural determinants of checkpoint activation. Genes Dev. 2007;21(8):898–903. doi: 10.1101/gad.1522607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Byun TS, Pacek M, Yee MC, Walter JC, Cimprich KA. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev. 2005;19(9):1040–1052. doi: 10.1101/gad.1301205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.You Z, Shi LZ, Zhu Q, Wu P, Zhang YW, Basilio A, Tonnu N, Verma IM, Berns MW, Hunter T. CtIP links DNA double-strand break sensing to resection. Mol Cell. 2009;36(6):954–969. doi: 10.1016/j.molcel.2009.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Giannattasio M, Follonier C, Tourriere H, Puddu F, Lazzaro F, Pasero P, Lopes M, Plevani P, Muzi-Falconi M. Exo1 competes with repair synthesis, converts NER intermediates to long ssDNA gaps, and promotes checkpoint activation. Mol Cell. 2010;40(1):50–62. doi: 10.1016/j.molcel.2010.09.004. [DOI] [PubMed] [Google Scholar]
- 100.Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 2003;300(5625):1542–1548. doi: 10.1126/science.1083430. [DOI] [PubMed] [Google Scholar]
- 101.Cortez D, Guntuku S, Qin J, Elledge SJ. ATR and ATRIP: partners in checkpoint signaling. Science. 2001;294(5547):1713–1716. doi: 10.1126/science.1065521. [DOI] [PubMed] [Google Scholar]
- 102.Ellison V, Stillman B. Biochemical characterization of DNA damage checkpoint complexes: clamp loader and clamp complexes with specificity for 5′ recessed DNA. PLoS Biol. 2003;1(2):E33. doi: 10.1371/journal.pbio.0000033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Parrilla-Castellar ER, Arlander SJ, Karnitz L. Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex. DNA Repair. 2004;3(8–9):1009–1014. doi: 10.1016/j.dnarep.2004.03.032. [DOI] [PubMed] [Google Scholar]
- 104.Bermudez VP, Lindsey-Boltz LA, Cesare AJ, Maniwa Y, Griffith JD, Hurwitz J, Sancar A. Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro. Proc Natl Acad Sci USA. 2003;100(4):1633–1638. doi: 10.1073/pnas.0437927100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Majka J, Binz SK, Wold MS, Burgers PM. Replication protein A directs loading of the DNA damage checkpoint clamp to 5′-DNA junctions. J Biol Chem. 2006;281(38):27855–27861. doi: 10.1074/jbc.M605176200. [DOI] [PubMed] [Google Scholar]
- 106.Kondo T, Wakayama T, Naiki T, Matsumoto K, Sugimoto K. Recruitment of Mec1 and Ddc1 checkpoint proteins to double-strand breaks through distinct mechanisms. Science. 2001;294(5543):867–870. doi: 10.1126/science.1063827. [DOI] [PubMed] [Google Scholar]
- 107.Melo JA, Cohen J, Toczyski DP. Two checkpoint complexes are independently recruited to sites of DNA damage in vivo. Genes Dev. 2001;15(21):2809–2821. doi: 10.1101/gad.903501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Kanoh Y, Tamai K, Shirahige K. Different requirements for the association of ATR-ATRIP and 9-1-1 to the stalled replication forks. Gene. 2006;377:88–95. doi: 10.1016/j.gene.2006.03.019. [DOI] [PubMed] [Google Scholar]
- 109.Garcia V, Furuya K, Carr AM. Identification and functional analysis of TopBP1 and its homologs. DNA Repair (Amst) 2005;4(11):1227–1239. doi: 10.1016/j.dnarep.2005.04.001. [DOI] [PubMed] [Google Scholar]
- 110.Sokka M, Parkkinen S, Pospiech H, Syvaoja JE. Function of TopBP1 in genome stability. Subcell Biochem. 2010;50:119–141. doi: 10.1007/978-90-481-3471-7_7. [DOI] [PubMed] [Google Scholar]
- 111.Van Hatten RA, Tutter AV, Holway AH, Khederian AM, Walter JC, Michael WM. The Xenopus Xmus101 protein is required for the recruitment of Cdc45 to origins of DNA replication. J Cell Biol. 2002;159(4):541–547. doi: 10.1083/jcb.200207090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Hashimoto Y, Takisawa H. Xenopus Cut5 is essential for a CDK-dependent process in the initiation of DNA replication. EMBO J. 2003;22(10):2526–2535. doi: 10.1093/emboj/cdg238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Kumagai A, Lee J, Yoo HY, Dunphy WG. TopBP1 activates the ATR-ATRIP complex. Cell. 2006;124(5):943–955. doi: 10.1016/j.cell.2005.12.041. [DOI] [PubMed] [Google Scholar]
- 114.Mordes DA, Glick GG, Zhao R, Cortez D. TopBP1 activates ATR through ATRIP and a PIKK regulatory domain. Genes Dev. 2008;22(11):1478–1489. doi: 10.1101/gad.1666208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.St Onge RP, Besley BD, Pelley JL, Davey S. A role for the phosphorylation of hRad9 in checkpoint signaling. J Biol Chem. 2003;278(29):26620–26628. doi: 10.1074/jbc.M303134200. [DOI] [PubMed] [Google Scholar]
- 116.Greer DA, Besley BDA, Kennedy KB, Davey S. hRad9 rapidly binds DNA containing double-strand breaks and is required for damage-dependent Topoisomerase II binding protein 1 focus formation. Cancer Res. 2003;63:4829–4835. [PubMed] [Google Scholar]
- 117.Furuya K, Poitelea M, Guo L, Caspari T, Carr AM. Chk1 activation requires Rad9 S/TQ-site phosphorylation to promote association with C-terminal BRCT domains of Rad4TOPBP1. Genes Dev. 2004;18(10):1154–1164. doi: 10.1101/gad.291104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Delacroix S, Wagner JM, Kobayashi M, Yamamoto K, Karnitz LM. The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1. Genes Dev. 2007;21(12):1472–1477. doi: 10.1101/gad.1547007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Yan S, Lindsay HD, Michael WM. Direct requirement for Xmus101 in ATR-mediated phosphorylation of Claspin bound Chk1 during checkpoint signaling. J Cell Biol. 2006;173(2):181–186. doi: 10.1083/jcb.200601076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Taricani L, Wang TS. Rad4TopBP1, a scaffold protein, plays separate roles in DNA damage and replication checkpoints and DNA replication. Mol Biol Cell. 2006;17(8):3456–3468. doi: 10.1091/mbc.E06-01-0056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Parrilla-Castellar ER, Karnitz LM. Cut5 is required for the binding of Atr and DNA polymerase alpha to genotoxin-damaged chromatin. J Biol Chem. 2003;278(46):45507–45511. doi: 10.1074/jbc.C300418200. [DOI] [PubMed] [Google Scholar]
- 122.Yan S, Michael WM. TopBP1 and DNA polymerase-alpha directly recruit the 9-1-1 complex to stalled DNA replication forks. J Cell Biol. 2009;184(6):793–804. doi: 10.1083/jcb.200810185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Gong Z, Kim JE, Leung CC, Glover JN, Chen J. BACH1/FANCJ acts with TopBP1 and participates early in DNA replication checkpoint control. Mol Cell. 2010;37(3):438–446. doi: 10.1016/j.molcel.2010.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Wang J, Gong Z, Chen J. MDC1 collaborates with TopBP1 in DNA replication checkpoint control. J Cell Biol. 2011;193(2):267–273. doi: 10.1083/jcb.201010026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Duursma AM, Driscoll R, Elias JE, Cimprich KA. A role for the MRN complex in ATR activation via TOPBP1 recruitment. Mol Cell. 2013;50(1):116–122. doi: 10.1016/j.molcel.2013.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Lee J, Dunphy WG. The Mre11-Rad50-Nbs1 (MRN) complex has a specific role in the activation of Chk1 in response to stalled replication forks. Mol Biol Cell. 2013;24(9):1343–1353. doi: 10.1091/mbc.E13-01-0025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Kumagai A, Dunphy WG. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol Cell. 2000;6(4):839–849. doi: 10.1016/s1097-2765(05)00092-4. [DOI] [PubMed] [Google Scholar]
- 128.Chini CC, Chen J. Human claspin is required for replication checkpoint control. J Biol Chem. 2003;278(32):30057–30062. doi: 10.1074/jbc.M301136200. [DOI] [PubMed] [Google Scholar]
- 129.Lin SY, Li K, Stewart GS, Elledge SJ. Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation. Proc Natl Acad Sci USA. 2004;101(17):6484–6489. doi: 10.1073/pnas.0401847101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Unsal-Kacmaz K, Mullen TE, Kaufmann WK, Sancar A. Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol. 2005;25(8):3109–3116. doi: 10.1128/MCB.25.8.3109-3116.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Unsal-Kacmaz K, Chastain PD, Qu PP, Minoo P, Cordeiro-Stone M, Sancar A, Kaufmann WK. The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement. Mol Cell Biol. 2007;27(8):3131–3142. doi: 10.1128/MCB.02190-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Errico A, Costanzo V, Hunt T. Tipin is required for stalled replication forks to resume DNA replication after removal of aphidicolin in Xenopus egg extracts. Proc Natl Acad Sci USA. 2007;104(38):14929–14934. doi: 10.1073/pnas.0706347104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Errico A, Costanzo V. Mechanisms of replication fork protection: a safeguard for genome stability. Crit Rev Biochem Mol Biol. 2012;47(3):222–235. doi: 10.3109/10409238.2012.655374. [DOI] [PubMed] [Google Scholar]
- 134.Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol. 2007;19(2):238–245. doi: 10.1016/j.ceb.2007.02.009. [DOI] [PubMed] [Google Scholar]
- 135.Yoo HY, Kumagai A, Shevchenko A, Dunphy WG. Adaptation of a DNA replication checkpoint response depends upon inactivation of Claspin by the Polo-like kinase. Cell. 2004;117(5):575–588. doi: 10.1016/s0092-8674(04)00417-9. [DOI] [PubMed] [Google Scholar]
- 136.Kulkarni A, Das KC. Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation. Am J Physiol Lung Cell Mol Physiol. 2008;294(5):L998–L1006. doi: 10.1152/ajplung.00004.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Yang Y, Durando M, Smith-Roe SL, Sproul C, Greenwalt AM, Kaufmann W, Oh S, Hendrickson EA, Vaziri C. Cell cycle stage-specific roles of Rad18 in tolerance and repair of oxidative DNA damage. Nucleic Acids Res. 2013;41(4):2296–2312. doi: 10.1093/nar/gks1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Jang SH, Lim JW, Morio T, Kim H. Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells. Free Radic Biol Med. 2012;52(3):607–615. doi: 10.1016/j.freeradbiomed.2011.11.010. [DOI] [PubMed] [Google Scholar]
- 139.Cuadrado M, Martinez-Pastor B, Murga M, Toledo LI, Gutierrez-Martinez P, Lopez E, Fernandez-Capetillo O. ATM regulates ATR chromatin loading in response to DNA double-strand breaks. J Exp Med. 2006;203(2):297–303. doi: 10.1084/jem.20051923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol. 2006;8(1):37–45. doi: 10.1038/ncb1337. [DOI] [PubMed] [Google Scholar]
- 141.Shiotani B, Zou L. Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. Mol Cell. 2009;33(5):547–558. doi: 10.1016/j.molcel.2009.01.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Gobbini E, Cesena D, Galbiati A, Lockhart A, Longhese MP. Interplays between ATM/Tel1 and ATR/Mec1 in sensing and signaling DNA double-strand breaks. DNA Repair (Amst) 2013;12(10):791–799. doi: 10.1016/j.dnarep.2013.07.009. [DOI] [PubMed] [Google Scholar]
- 143.Caporali S, Falcinelli S, Starace G, Russo MT, Bonmassar E, Jiricny J, D’Atri S. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system. Mol Pharmacol. 2004;66(3):478–491. doi: 10.1124/mol.66.3.. [DOI] [PubMed] [Google Scholar]
- 144.Stiff T, Walker SA, Cerosaletti K, Goodarzi AA, Petermann E, Concannon P, O’Driscoll M, Jeggo PA. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 2006;25(24):5775–5782. doi: 10.1038/sj.emboj.7601446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Yajima H, Lee KJ, Zhang S, Kobayashi J, Chen BP. DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases. J Mol Biol. 2009;385(3):800–810. doi: 10.1016/j.jmb.2008.11.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Bauer M, Goldstein M, Christmann M, Becker H, Heylmann D, Kaina B. Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc Natl Acad Sci USA. 2011;108(52):21105–21110. doi: 10.1073/pnas.1111919109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Chaudhary P, Sharma R, Sahu M, Vishwanatha JK, Awasthi S, Awasthi YC. 4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway. J Biol Chem. 2013;288(28):20532–20546. doi: 10.1074/jbc.M113.467662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Ward IM, Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem. 2001;276(51):47759–47762. doi: 10.1074/jbc.C100569200. [DOI] [PubMed] [Google Scholar]
- 149.Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem. 2001;276(45):42462–42467. doi: 10.1074/jbc.C100466200. [DOI] [PubMed] [Google Scholar]
- 150.Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000;408(6811):433–439. doi: 10.1038/35044005. [DOI] [PubMed] [Google Scholar]
- 151.Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer. 2012;12(12):801–817. doi: 10.1038/nrc3399. [DOI] [PubMed] [Google Scholar]
- 152.Slupphaug G. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res. 2003;531(1–2):231–251. doi: 10.1016/j.mrfmmm.2003.06.002. [DOI] [PubMed] [Google Scholar]
- 153.Meira LB, Burgis NE, Samson LD. Base excision repair. Adv Exp Med Biol. 2005;570:125–173. doi: 10.1007/1-4020-3764-3_5. [DOI] [PubMed] [Google Scholar]
- 154.Cao W. Endonuclease V: an unusual enzyme for repair of DNA deamination. Cell Mol Life Sci. 2013;70(17):3145–3156. doi: 10.1007/s00018-012-1222-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155.Svilar D, Goellner EM, Almeida KH, Sobol RW. Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage. Antioxid Redox Signal. 2011;14(12):2491–2507. doi: 10.1089/ars.2010.3466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.Krokan HE, Bjoras M. Base excision repair. Cold Spring Harb Perspect Biol. 2013;5(4):a012583. doi: 10.1101/cshperspect.a012583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Caldecott KW. Single-strand break repair and genetic disease. Nat Rev Genet. 2008;9(8):619–631. doi: 10.1038/nrg2380. [DOI] [PubMed] [Google Scholar]
- 158.Melis JP, van Steeg H, Luijten M. Oxidative DNA damage and nucleotide excision repair. Antioxid Redox Signal. 2013;18(18):2409–2419. doi: 10.1089/ars.2012.5036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.Batty DP, Wood RD. Damage recognition in nucleotide excision repair of DNA. Gene. 2000;241(2):193–204. doi: 10.1016/s0378-1119(99)00489-8. [DOI] [PubMed] [Google Scholar]
- 160.Guo C, Tang TS, Friedberg EC. SnapShot: nucleotide excision repair. Cell. 2010;140(5):754–754.e1. doi: 10.1016/j.cell.2010.02.033. [DOI] [PubMed] [Google Scholar]
- 161.Brierley DJ, Martin SA. Oxidative stress and the DNA mismatch repair pathway. Antioxid Redox Signal. 2013;18(18):2420–2428. doi: 10.1089/ars.2012.4994. [DOI] [PubMed] [Google Scholar]
- 162.Jiricny J. Postreplicative mismatch repair. Cold Spring Harb Perspect Biol. 2013;5(4):a012633. doi: 10.1101/cshperspect.a012633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem. 2008;77:229–257. doi: 10.1146/annurev.biochem.77.061306.125255. [DOI] [PubMed] [Google Scholar]
- 164.Symington LS, Gautier J. Double-strand break end resection and repair pathway choice. Annu Rev Genet. 2011;45:247–271. doi: 10.1146/annurev-genet-110410-132435. [DOI] [PubMed] [Google Scholar]
- 165.Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181–211. doi: 10.1146/annurev.biochem.052308.093131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Sirbu BM, Cortez D. DNA damage response: three levels of DNA repair regulation. Cold Spring Harb Perspect Biol. 2013;5(8):a012724. doi: 10.1101/cshperspect.a012724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Helt CE, Wang W, Keng PC, Bambara RA. Evidence that DNA damage detection machinery participates in DNA repair. Cell Cycle. 2005;4(4):529–532. doi: 10.4161/cc.4.4.1598. [DOI] [PubMed] [Google Scholar]
- 168.Chou WC, Wang HC, Wong FH, Ding SL, Wu PE, Shieh SY, Shen CY. Chk2-dependent phosphorylation of XRCC1 in the DNA damage response promotes base excision repair. EMBO J. 2008;27(23):3140–3150. doi: 10.1038/emboj.2008.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Meagher M, Lightowlers RN. The role of TDP1 and APTX in mitochondrial DNA repair. Biochimie. 2014;100:121–124. doi: 10.1016/j.biochi.2013.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 170.Das BB, Antony S, Gupta S, Dexheimer TS, Redon CE, Garfield S, Shiloh Y, Pommier Y. Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. EMBO J. 2009;28(23):3667–3680. doi: 10.1038/emboj.2009.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171.Povirk LF (2012) Processing of damaged DNA ends for double-strand break repair in mammalian cells. ISRN Mol Biol 2012:345805. doi:10.5402/2012/345805 [DOI] [PMC free article] [PubMed]
- 172.Qi Y, Schoene NW, Lartey FM, Cheng WH. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells. J Biol Chem. 2010;285(43):33010–33017. doi: 10.1074/jbc.M110.137406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173.Romeo F, Falbo L, Di Sanzo M, Misaggi R, Faniello MC, Viglietto G, Cuda G, Costanzo F, Quaresima B. BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage. Int J Biochem Cell Biol. 2011;43(12):1754–1763. doi: 10.1016/j.biocel.2011.08.011. [DOI] [PubMed] [Google Scholar]
- 174.Lee JH, Kim KH, Morio T, Kim H. Ataxia-telangiectasia-mutated-dependent activation of Ku in human fibroblasts exposed to hydrogen peroxide. Ann NY Acad Sci. 2006;1091:76–82. doi: 10.1196/annals.1378.056. [DOI] [PubMed] [Google Scholar]
- 175.Kuhne C, Tjornhammar ML, Pongor S, Banks L, Simoncsits A. Repair of a minimal DNA double-strand break by NHEJ requires DNA-PKcs and is controlled by the ATM/ATR checkpoint. Nucleic Acids Res. 2003;31(24):7227–7237. doi: 10.1093/nar/gkg937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Di Virgilio M, Ying CY, Gautier J. PIKK-dependent phosphorylation of Mre11 induces MRN complex inactivation by disassembly from chromatin. DNA Repair (Amst) 2009;8(11):1311–1320. doi: 10.1016/j.dnarep.2009.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Toueille M, El-Andaloussi N, Frouin I, Freire R, Funk D, Shevelev I, Friedrich-Heineken E, Villani G, Hottiger MO, Hubscher U. The human Rad9/Rad1/Hus1 damage sensor clamp interacts with DNA polymerase beta and increases its DNA substrate utilisation efficiency: implications for DNA repair. Nucleic Acids Res. 2004;32(11):3316–3324. doi: 10.1093/nar/gkh652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 178.Wang W, Brandt P, Rossi ML, Lindsey-Boltz L, Podust V, Fanning E, Sancar A, Bambara RA. The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1. Proc Natl Acad Sci USA. 2004;101(48):16762–16767. doi: 10.1073/pnas.0407686101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Chang DY, Lu AL. Interaction of checkpoint proteins Hus1/Rad1/Rad9 with DNA base excision repair enzyme MutY homolog in fission yeast, Schizosaccharomyces pombe. J Biol Chem. 2005;280(1):408–417. doi: 10.1074/jbc.M406800200. [DOI] [PubMed] [Google Scholar]
- 180.Friedrich-Heineken E, Toueille M, Tannler B, Burki C, Ferrari E, Hottiger MO, Hubscher U. The two DNA clamps Rad9/Rad1/Hus1 complex and proliferating cell nuclear antigen differentially regulate flap endonuclease 1 activity. J Mol Biol. 2005;353(5):980–989. doi: 10.1016/j.jmb.2005.09.018. [DOI] [PubMed] [Google Scholar]
- 181.Smirnova E, Toueille M, Markkanen E, Hubscher U. The human checkpoint sensor and alternative DNA clamp Rad9-Rad1-Hus1 modulates the activity of DNA ligase I, a component of the long-patch base excision repair machinery. Biochem J. 2005;389(Pt 1):13–17. doi: 10.1042/BJ20050211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 182.Wang W, Lindsey-Boltz LA, Sancar A, Bambara RA. Mechanism of stimulation of human DNA ligase I by the Rad9-rad1-Hus1 checkpoint complex. J Biol Chem. 2006;281(30):20865–20872. doi: 10.1074/jbc.M602289200. [DOI] [PubMed] [Google Scholar]
- 183.Guan X, Bai H, Shi G, Theriot CA, Hazra TK, Mitra S, Lu AL. The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates NEIL1 glycosylase. Nucleic Acids Res. 2007;35(8):2463–2472. doi: 10.1093/nar/gkm075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184.Gembka A, Toueille M, Smirnova E, Poltz R, Ferrari E, Villani G, Hubscher U. The checkpoint clamp, Rad9-Rad1-Hus1 complex, preferentially stimulates the activity of apurinic/apyrimidinic endonuclease 1 and DNA polymerase beta in long patch base excision repair. Nucleic Acids Res. 2007;35(8):2596–2608. doi: 10.1093/nar/gkl1139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185.Guan X, Madabushi A, Chang DY, Fitzgerald ME, Shi G, Drohat AC, Lu AL. The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates DNA repair enzyme TDG glycosylase. Nucleic Acids Res. 2007;35(18):6207–6218. doi: 10.1093/nar/gkm678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186.Dore AS, Kilkenny ML, Rzechorzek NJ, Pearl LH. Crystal structure of the rad9-rad1-hus1 DNA damage checkpoint complex–implications for clamp loading and regulation. Mol Cell. 2009;34(6):735–745. doi: 10.1016/j.molcel.2009.04.027. [DOI] [PubMed] [Google Scholar]
- 187.Wu X, Shell SM, Yang Z, Zou Y. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation. Cancer Res. 2006;66(6):2997–3005. doi: 10.1158/0008-5472.CAN-05-3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 188.Wu X, Shell SM, Liu Y, Zou Y. ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation. Oncogene. 2007;26(5):757–764. doi: 10.1038/sj.onc.1209828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 189.Auclair Y, Rouget R, el Affar B, Drobetsky EA. ATR kinase is required for global genomic nucleotide excision repair exclusively during S phase in human cells. Proc Natl Acad Sci USA. 2008;105(46):17896–17901. doi: 10.1073/pnas.0801585105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Lee TH, Park JM, Leem SH, Kang TH. Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair. Oncogene. 2012;33(1):19–25. doi: 10.1038/onc.2012.539. [DOI] [PubMed] [Google Scholar]
- 191.Li Z, Musich PR, Zou Y. Differential DNA damage responses in p53 proficient and deficient cells: cisplatin-induced nuclear import of XPA is independent of ATR checkpoint in p53-deficient lung cancer cells. Int J Biochem Mol Biol. 2011;2(2):138–145. [PMC free article] [PubMed] [Google Scholar]
- 192.Auclair Y, Rouget R, Drobetsky EA. ATR kinase as master regulator of nucleotide excision repair during S phase of the cell cycle. Cell Cycle. 2009;8(12):1865–1871. doi: 10.4161/cc.8.12.8800. [DOI] [PubMed] [Google Scholar]
- 193.Patil M, Pabla N, Dong Z. Checkpoint kinase 1 in DNA damage response and cell cycle regulation. Cell Mol Life Sci. 2013;70(21):4009–4021. doi: 10.1007/s00018-013-1307-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 194.Yang XH, Shiotani B, Classon M, Zou L. Chk1 and Claspin potentiate PCNA ubiquitination. Genes Dev. 2008;22(9):1147–1152. doi: 10.1101/gad.1632808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 195.Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J, Helleday T. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol. 2005;7(2):195–201. doi: 10.1038/ncb1212. [DOI] [PubMed] [Google Scholar]
- 196.Brown KD, Rathi A, Kamath R, Beardsley DI, Zhan Q, Mannino JL, Baskaran R. The mismatch repair system is required for S-phase checkpoint activation. Nat Genet. 2003;33(1):80–84. doi: 10.1038/ng1052. [DOI] [PubMed] [Google Scholar]
- 197.Yoshioka K, Yoshioka Y, Hsieh P. ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Mol Cell. 2006;22(4):501–510. doi: 10.1016/j.molcel.2006.04.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 198.Arcangioli B, Ben Hassine S. Unrepaired oxidative DNA damage induces an ATR/ATM apoptotic-like response in quiescent fission yeast. Cell Cycle. 2009;8(15):2326–2331. doi: 10.4161/cc.8.15.9147. [DOI] [PubMed] [Google Scholar]
- 199.Brem R, Fernet M, Chapot B, Hall J. The methyl methanesulfonate induced S-phase delay in XRCC1-deficient cells requires ATM and ATR. DNA Repair (Amst) 2008;7(6):849–857. doi: 10.1016/j.dnarep.2008.02.002. [DOI] [PubMed] [Google Scholar]
- 200.Marini F, Nardo T, Giannattasio M, Minuzzo M, Stefanini M, Plevani P, Muzi Falconi M. DNA nucleotide excision repair-dependent signaling to checkpoint activation. Proc Natl Acad Sci USA. 2006;103(46):17325–17330. doi: 10.1073/pnas.0605446103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 201.Oh KS, Bustin M, Mazur SJ, Appella E, Kraemer KH. UV-induced histone H2AX phosphorylation and DNA damage related proteins accumulate and persist in nucleotide excision repair-deficient XP-B cells. DNA Repair (Amst) 2011;10(1):5–15. doi: 10.1016/j.dnarep.2010.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 202.Marti TM, Hefner E, Feeney L, Natale V, Cleaver JE. H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. Proc Natl Acad Sci USA. 2006;103(26):9891–9896. doi: 10.1073/pnas.0603779103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 203.Ray A, Milum K, Battu A, Wani G, Wani AA. NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites. DNA Repair (Amst) 2013;12(4):273–283. doi: 10.1016/j.dnarep.2013.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 204.Colton SL, Xu XS, Wang YA, Wang G. The involvement of ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment. J Biol Chem. 2006;281(37):27117–27125. doi: 10.1074/jbc.M602826200. [DOI] [PubMed] [Google Scholar]
- 205.Sertic S, Pizzi S, Cloney R, Lehmann AR, Marini F, Plevani P, Muzi-Falconi M. Human exonuclease 1 connects nucleotide excision repair (NER) processing with checkpoint activation in response to UV irradiation. Proc Natl Acad Sci USA. 2011;108(33):13647–13652. doi: 10.1073/pnas.1108547108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 206.Lindsey-Boltz LA, Kemp MG, Reardon JT, Derocco V, Iyer RR, Modrich P, Sancar A. Coupling of human DNA excision repair and the DNA damage checkpoint in a defined in vitro system. J Biol Chem. 2014;289(8):5074–5082. doi: 10.1074/jbc.M113.542787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 207.Stojic L, Brun R, Jiricny J. Mismatch repair and DNA damage signalling. DNA Repair (Amst) 2004;3(8–9):1091–1101. doi: 10.1016/j.dnarep.2004.06.006. [DOI] [PubMed] [Google Scholar]
- 208.Franchitto A, Pichierri P, Piergentili R, Crescenzi M, Bignami M, Palitti F. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase. Oncogene. 2003;22(14):2110–2120. doi: 10.1038/sj.onc.1206254. [DOI] [PubMed] [Google Scholar]
- 209.Liu A, Yoshioka K, Salerno V, Hsieh P. The mismatch repair-mediated cell cycle checkpoint response to fluorodeoxyuridine. J Cell Biochem. 2008;105(1):245–254. doi: 10.1002/jcb.21824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 210.Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–338. doi: 10.1038/nrc1074. [DOI] [PubMed] [Google Scholar]
- 211.An Q, Robins P, Lindahl T, Barnes DE. 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity. Cancer Res. 2007;67(3):940–945. doi: 10.1158/0008-5472.CAN-06-2960. [DOI] [PubMed] [Google Scholar]
- 212.Wang Y, Qin J. MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation. Proc Natl Acad Sci USA. 2003;100(26):15387–15392. doi: 10.1073/pnas.2536810100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 213.Stojic L, Mojas N, Cejka P, Di Pietro M, Ferrari S, Marra G, Jiricny J. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev. 2004;18(11):1331–1344. doi: 10.1101/gad.294404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 214.Liu Y, Fang Y, Shao H, Lindsey-Boltz L, Sancar A, Modrich P. Interactions of human mismatch repair proteins MutSalpha and MutLalpha with proteins of the ATR-Chk1 pathway. J Biol Chem. 2010;285(8):5974–5982. doi: 10.1074/jbc.M109.076109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 215.Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005;4(4):307–320. doi: 10.1038/nrd1691. [DOI] [PubMed] [Google Scholar]
- 216.Pabla N, Huang S, Mi QS, Daniel R, Dong Z. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem. 2008;283(10):6572–6583. doi: 10.1074/jbc.M707568200. [DOI] [PubMed] [Google Scholar]
- 217.Pabla N, Ma Z, McIlhatton MA, Fishel R, Dong Z. hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. J Biol Chem. 2011;286(12):10411–10418. doi: 10.1074/jbc.M110.210989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 218.Williams RS, Williams JS, Tainer JA. Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template. Biochem Cell Biol. 2007;85(4):509–520. doi: 10.1139/O07-069. [DOI] [PubMed] [Google Scholar]
- 219.Soutoglou E, Misteli T. Activation of the cellular DNA damage response in the absence of DNA lesions. Science. 2008;320(5882):1507–1510. doi: 10.1126/science.1159051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 220.Sartori AA, Lukas C, Coates J, Mistrik M, Fu S, Bartek J, Baer R, Lukas J, Jackson SP. Human CtIP promotes DNA end resection. Nature. 2007;450(7169):509–514. doi: 10.1038/nature06337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 221.Nakada D, Hirano Y, Sugimoto K. Requirement of the Mre11 complex and exonuclease 1 for activation of the Mec1 signaling pathway. Mol Cell Biol. 2004;24(22):10016–10025. doi: 10.1128/MCB.24.22.10016-10025.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 222.Kastan MS, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432:316–323. doi: 10.1038/nature03097. [DOI] [PubMed] [Google Scholar]